Globus Medical, Inc.

NYSE:GMED

81.97 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009
Operating Activities:
Net Income 122.873190.169149.191102.285155.21156.474107.348104.341112.78492.48568.61273.83160.78454.45852.033
Depreciation & Amortization 144.73368.25269.86762.87452.73441.6342.06738.77124.08421.75419.39718.10816.94915.19613.502
Deferred Income Tax -57.789-22.223-17.615-4.3384.3020.9718.292-3.816.235-4.379-14.858-6.0792.0571.999-2.654
Stock Based Compensation 52.74232.8130.58627.07326.08521.89914.68611.3829.6397.1115.1774.6353.2864.0253.511
Change In Working Capital -116.598-105.262-17.252-37.59-73.444-49.868-30.5223.485-43.478-47.7596.238-20.577-17.292-10.661-39.747
Accounts Receivables -49.914-50.843-25.89510.696-18.306-21.789-24.955-4.668-4.193-12.667-9.612-6.886-4.672-6.56-11.963
Inventory -70.328-61.745-11.971-50.111-50.018-31.382-5.277-10.503-19.327-18.001-16.678-20.541-15.28-10.188-18.478
Accounts Payables -14.22314.4183.684-6.3520.773-3.0089.843-0.023-9.1847.3311.944.426-2.0512.72-2.186
Other Working Capital 17.867-7.09216.938.177-5.8936.311-10.13318.679-10.774-24.42230.5882.4244.7113.367-7.12
Other Non Cash Items 97.53814.72261.49748.4897.08810.53717.66417.72412.6939.968.9056.60110.6266.2715.434
Operating Cash Flow 243.499178.468276.274198.793171.975181.643159.535171.893121.95779.17293.47176.51976.4171.28832.079
Investing Activities:
Investments In Property Plant And Equipment -78.274-74.047-56.898-63.658-70.75-59.697-51.303-40.909-50.76-24.754-23.68-24.684-22.487-12.303-25.963
Acquisitions Net -296.028-31.435-34.488-33.483-23.799-14.825-29.944-76.068-48.513-36.128-16.775-6.031-7.50-3.371
Purchases Of Investments -100.643-419.534-622.359-223.54-346.526-537.942-392.895-287.263-297.707-251.422-240.8920000
Sales Maturities Of Investments 777.913414.654337.806203.359300.794384.437362.865334.687246.43212.30454.197000.31.639
Other Investing Activites 677.27-4.88-284.553-20.181-45.73235-30.03-30-53.777-39.118-186.695-6.031000
Investing Cash Flow 302.968-110.362-375.939-117.322-140.281-193.027-111.277-99.553-150.55-100-227.15-30.715-29.987-12.003-27.695
Financing Activities:
Debt Repayment 000000000000-5.253-0.34-0.531
Common Stock Issued 12.39741.71663.49672.32231.03639.30911.7355.8745.4779.7387.55522.4640.8861.3210.918
Common Stock Repurchased -225.562-144.4930-104.66900000000-10.02100
Dividends Paid 000000000000000
Other Financing Activities -18.656-7.185-9.349-6.316-6.597-6.739-10.109-3.8330.853.2083.4561.561-0.3460.7871.107
Financing Cash Flow -231.821-109.96254.147-38.66324.43932.571.6262.0416.32712.94611.01124.025-14.7341.7681.494
Other Information:
Effect Of Forex Changes On Cash 2.18-0.747-0.810.865-0.156-0.2561.979-1.8940.1530.1850.23-0.097-0.722-0.0020.05
Net Change In Cash 316.826-42.603-46.32843.67355.97720.9351.86372.487-22.113-7.697-122.43869.73230.96761.0515.928
Cash At End Of Period 467.292150.466193.069239.397195.724139.747118.817132.63960.15282.26589.962212.4142.668111.70150.65